{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T18:51:39Z","timestamp":1780426299365,"version":"3.54.1"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1565,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1111\/j.1365-2133.2011.10344.x","type":"journal-article","created":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T16:14:35Z","timestamp":1301674475000},"page":"1376-1382","source":"Crossref","is-referenced-by-count":49,"title":["A 6-month maintenance therapy with adapalene-benzoyl peroxide gel prevents relapse and continuously improves efficacy among patients with severe acne vulgaris: results of a randomized controlled trial"],"prefix":"10.1093","volume":"164","author":[{"given":"Y.","family":"Poulin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.P.","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bucko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Jarratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kempers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Kerrouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-C.","family":"Dhuin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Kunynetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,5,20]]},"reference":[{"key":"10.1111\/j.1365-2133.2011.10344.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2165\/00128071-200809050-00001","article-title":"Can we define acne as a chronic disease?","volume":"9","author":"Gollnick","year":"2008","journal-title":"Am J Clin Dermatol"},{"issue":"Suppl.","key":"10.1111\/j.1365-2133.2011.10344.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaad.2009.01.019","article-title":"New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group","volume":"60","author":"Thiboutot","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10344.x-BIB3|cit3","first-page":"4","article-title":"Physiopathology of acne vulgaris: recent data, new understanding of the treatments","volume":"14","author":"Pawin","year":"2004","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10344.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1540-9740.2003.02037.x","article-title":"How do you foster medication adherence for better acne vulgaris management?","volume":"2","author":"Koo","year":"2003","journal-title":"Skinmed"},{"key":"10.1111\/j.1365-2133.2011.10344.x-BIB5|cit5","first-page":"963","article-title":"Relapse of acne following isotretinoin treatment: a retrospective study of 405 patients","volume":"7","author":"Liu","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10344.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000090658","article-title":"Prospective study of risk factors of relapse after treatment of acne with oral isotretinoin","volume":"212","author":"Qu\u00e9reux","year":"2006","journal-title":"Dermatology"},{"issue":"Suppl.","key":"10.1111\/j.1365-2133.2011.10344.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"S200","DOI":"10.1067\/S0190-9622(03)01154-X","article-title":"A review of the use of combination therapies for the treatment of acne vulgaris","volume":"49","author":"Leyden","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl.","key":"10.1111\/j.1365-2133.2011.10344.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mjd.2003.618","article-title":"Management of acne. A report from a Global Alliance to Improve Outcomes in Acne","volume":"49","author":"Gollnick","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10344.x-BIB9|cit9","first-page":"278","article-title":"Adapalene-benzoyl peroxide, a new fixed dose combination for the treatment of acne vulgaris: a randomized, bilateral (split-face), dose-assessment study of cutaneous tolerability in healthy subjects","volume":"81","author":"Andres","year":"2008","journal-title":"Cutis"},{"key":"10.1111\/j.1365-2133.2011.10344.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaad.2007.06.006","article-title":"Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study","volume":"57","author":"Thiboutot","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10344.x-BIB11|cit11","first-page":"110","article-title":"A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne","volume":"84","author":"Stein Gold","year":"2009","journal-title":"Cutis"},{"key":"10.1111\/j.1365-2133.2011.10344.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/j.1365-2133.2009.09209.x","article-title":"Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients","volume":"161","author":"Gollnick","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10344.x-BIB13|cit13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2010.03.036","article-title":"The efficacy of adapalene-benzoyl peroxide combination increases with number of acne lesions","author":"Feldman","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10344.x-BIB14|cit14","first-page":"94","article-title":"Effective and safe combination therapy for severe acne vulgaris: a randomized, vehicle-controlled, double-blind study of adapalene 0\u00b71%-benzoyl peroxide 2\u00b75% fixed-dose combination gel with doxycycline hyclate 100\u2003mg","volume":"85","author":"Stein Gold","year":"2010","journal-title":"Cutis"},{"issue":"Suppl.","key":"10.1111\/j.1365-2133.2011.10344.x-BIB15|cit15","first-page":"9","article-title":"Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance","volume":"79","author":"Leyden","year":"2007","journal-title":"Cutis"},{"key":"10.1111\/j.1365-2133.2011.10344.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1001\/archderm.142.5.597","article-title":"Adapalene gel, 0\u00b71% as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study","volume":"142","author":"Thiboutot","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10344.x-BIB17|cit17","first-page":"45","article-title":"Daily treatment with adapalene gel 0\u00b71% maintains initial improvement of acne vulgaris previously treated with oral lymecycline","volume":"17","author":"Alirezai","year":"2007","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10344.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1468-3083.2007.02190.x","article-title":"Control of microcomedone formation throughout a maintenance treatment with adapalene gel, 0\u00b71%","volume":"21","author":"Thielitz","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2011.10344.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/09546630410021702","article-title":"A successful maintenance approach in inflammatory acne with adapalene gel 0\u00b71% after an initial treatment in combination with clindamycin topical solution 1% or after monotherapy with clindamycin topical solution 1%","volume":"15","author":"Zhang","year":"2004","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/j.1365-2133.2011.10344.x-BIB20|cit20","first-page":"899","article-title":"Long-term safety and efficacy of a unique fixed-dose combination gel of adapalene 0\u00b71% and benzoyl peroxide 2\u00b75% for the treatment of acne vulgaris","volume":"6","author":"Pariser","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10344.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/247553030208a00301","article-title":"Definitions of measures of effect duration for psoriasis treatments","volume":"8","author":"Gordon","year":"2002","journal-title":"Psoriasis Forum"},{"issue":"4 Suppl. 1","key":"10.1111\/j.1365-2133.2011.10344.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1016\/j.jaad.2005.10.029","article-title":"Relapse, rebound, and psoriasis adverse events: an advisory group report","volume":"54","author":"Carey","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10344.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000090646","article-title":"The truth behind this undeniable efficacy - recurrence rates and relapse risk factors of acne treatment with oral isotretinoin","volume":"212","author":"Zouboulis","year":"2006","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2011.10344.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1540-9740.2004.03244.x","article-title":"Maintenance therapy for acne vulgaris: the fine balance between efficacy, cutaneous tolerability, and adherence","volume":"3","author":"Wolf","year":"2004","journal-title":"Skinmed"},{"key":"10.1111\/j.1365-2133.2011.10344.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1001\/archderm.142.5.638","article-title":"Acne maintenance therapy: expanding the role of topical retinoids?","volume":"142","author":"Zane","year":"2006","journal-title":"Arch Dermatol"},{"issue":"Suppl.","key":"10.1111\/j.1365-2133.2011.10344.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1067\/S0190-9622(03)01151-4","article-title":"Cumulative irritancy comparison of adapalene gel 0\u00b71% versus other retinoid products when applied in combination with topical antimicrobial agents","volume":"49","author":"Brand","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10344.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1016\/S0190-9622(97)70053-7","article-title":"Skin tolerance of adapalene 0\u00b71% gel in combination with other topical antiacne treatments","volume":"36","author":"Caron","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10344.x-BIB28|cit28","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-59715-2","volume-title":"Acne and Rosacea","author":"Plewig","year":"2000"},{"key":"10.1111\/j.1365-2133.2011.10344.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1128\/AAC.21.5.770","article-title":"Suppression of polymorphonuclear leukocyte chemotactic factor production in Propionibacterium acnes by subminimal inhibitory concentrations of tetracyclines and erythromycin","volume":"21","author":"Webster","year":"1982","journal-title":"Antimicrob Agents Chemother"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2011.10344.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2011.10344.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:51:58Z","timestamp":1676382718000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/164\/6\/1376\/6644353"}},"subtitle":["Adapalene-BPO maintenance therapy prevents relapse"],"short-title":[],"issued":{"date-parts":[[2011,5,20]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10344.x","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5,20]]}}}